BioCT presents a virtual panel re COVID-19: Current pipeline and innovations for therapeutics and vaccine
Please join Connecticut companies that are working on COVID-19 for a panel discussion on the current state of therapeutic and vaccine pipelines, new developments, and future plans.
Wednesday, April 8, 2020
10:30 am – 12:00 noon
Moderator:
Mostafa Analoui, PhD, Executive Director of Venture Development, Office of the Vice President for Research & Technology Incubation Program (TIP), UConn
Panelists:
- Mark Noe, PhD, Vice President of Medicine Design, Pfizer
- Mark Adams, PhD, Professor & Director, General Manager Microbial Genomic Services, The Jackson Laboratory
- Bijan Almassian, PhD, President & CEO, CaroGen
- Eric Kabrams, 4Catalyzer
- Anil Diwan, PhD, Executive Chairman & President, NanoViricides
- Gary Mathias, Co-Founder & CEO, Thetis Pharmaceuticals